This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Bio-Techne Corp. slipped 4.0% to $48.81 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.0% to 6,699.38 and the Dow Jones Industrial Average rising 0.8% to 46,946.41.
This was the stock's third consecutive day of losses.
Bio-Techne Corp. closed 32.4% below its 52-week high of $72.16, which the company achieved on January 22nd.
The stock underperformed when compared to some of its peers, as Amgen Inc. remained unchanged, Charles River Laboratories International Inc. fell 2.2% to $151.97, and BioMarin Pharmaceutical Inc. fell 1.85% to $57.43.
Trading volume totaled 3.0 million, compared to the 50-day average of 2.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 16, 2026 16:34 ET (20:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.